Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Beta Drugs IPO and Shree Ganesh Remedies IPO.
Beta Drugs IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Shree Ganesh Remedies IPO is a SME Fixed Price Issue proposed to list at BSE SME.
| Beta Drugs IPO | Shree Ganesh Remedies IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Pantomath Capital Advisors Pvt Ltd | Fedex Securities Pvt Ltd |
| Registrar | Link Intime India Private Ltd | Bigshare Services Pvt Ltd |
| Market Maker | ||
| DRHP | ||
| RHP | RHP  |
RHP |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Beta Drugs IPO is up to ₹19.52 Cr whereas the issue size of the Shree Ganesh Remedies IPO is up to ₹8.55 Cr. The final issue price of Beta Drugs IPO is ₹85.00 per share and of Shree Ganesh Remedies IPO is ₹36.00 per share.
| Beta Drugs IPO | Shree Ganesh Remedies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹85.00 per share | ₹36.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 3000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 22,96,000 shares | 23,76,000 shares |
| Issue Size Total (Amount) | up to ₹19.52 Cr | up to ₹8.55 Cr |
Beta Drugs IPO opens on Sep 29, 2017, while Shree Ganesh Remedies IPO opens on Sep 28, 2017. The closing date of Beta Drugs IPO and Shree Ganesh Remedies IPO is Oct 04, 2017, and Oct 05, 2017, respectively.
| Beta Drugs IPO | Shree Ganesh Remedies IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 29, 2017 | Sep 28, 2017 |
| Issue Close | Oct 04, 2017 | Oct 05, 2017 |
| Basis Of Allotment (Tentative) | Oct 10, 2017 | |
| Initiation of Refunds (Tentative) | Oct 11, 2017 | |
| Credit of Share (Tentative) | Oct 12, 2017 | |
| Listing date (Tentative) | Oct 13, 2017 | |
| Anchor Lockin End date 1 | Nov 09, 2017 | |
| Anchor Lockin End date 2 | Jan 08, 2018 |
Beta Drugs IPO P/E ratio is , as compared to Shree Ganesh Remedies IPO P/E ratio of .
| Beta Drugs IPO | Shree Ganesh Remedies IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Beta Drugs IPO retail investors (RII) are offered while in Shree Ganesh Remedies IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Beta Drugs IPO and in Shree Ganesh Remedies IPO.
| Beta Drugs IPO | Shree Ganesh Remedies IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Beta Drugs IPO subscribed in total, whereas Shree Ganesh Remedies IPO subscribed .
| Beta Drugs IPO | Shree Ganesh Remedies IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
